# Cell Transfection: Principles, Methods, and Applications ## Introduction to Cell Transfection ### What is Transfection? Cell transfection is the process of deliberately introducing exogenous nucleic acids—DNA, RNA, or small oligonucleotides—into eukaryotic cells. The term derives from "trans-" (across) and "-fection" (to make or do), reflecting the transfer of genetic material across the plasma membrane into the intracellular space. This technique is foundational to modern [molecular biology](/blog/careers/molecular-biology), enabling researchers to study gene function, produce recombinant proteins, silence specific genes, and edit the genome. The purpose of transfection extends beyond simply getting nucleic acids inside a cell. The ultimate goal is to achieve a biological effect: expression of a protein from a delivered plasmid, knockdown of an endogenous transcript via [small interfering RNA](/knowledge/molecular-biology/small-interfering-rna) (siRNA), or introduction of a site-specific double-strand break through CRISPR-Cas9 components. The efficiency with which these outcomes are achieved depends on the method chosen, the cell type, and the quality of the nucleic acid preparation. Transfection is performed on adherent or suspension cell lines, primary cells, and stem cells. Each cell type presents distinct challenges. Immortalized lines such as HEK293 or HeLa are generally permissive to most methods, while primary neurons or immune cells require specialized approaches. The choice of method is therefore dictated by the experimental question, the cell system, and the downstream application. ### Transfection vs. Transduction vs. Transformation These three terms are frequently confused, yet they describe fundamentally distinct processes. **Transfection** refers specifically to the introduction of nucleic acids into eukaryotic cells through non-viral or viral means. When a viral vector is used, the process is more precisely called **transduction**. Transduction exploits the natural ability of viruses to enter cells and deliver their genetic cargo. The viral genome is modified to carry a gene of interest, and the resulting recombinant virus infects target cells, depositing the transgene into the nucleus. **Transformation** has two meanings depending on context. In bacterial and yeast systems, transformation is the uptake of naked DNA from the environment—a process that requires the cell to be made competent, typically through chemical treatment (calcium chloride) or electroporation. In mammalian cell biology, transformation refers to the conversion of a normal cell into a cancerous phenotype, often through the introduction of oncogenes. The term is also used in the context of immortalizing primary cells. A useful summary distinction: transfection is non-viral (or viral) delivery into eukaryotes, transduction is exclusively viral delivery into eukaryotes, and transformation is DNA uptake by prokaryotes or the oncogenic conversion of eukaryotic cells. In practice, when working with mammalian cells, you will transfect; when working with bacteria, you will transform; and when using a viral vector, you will transduce. ## The Mechanism of Transfection ### Cellular Uptake Pathways The plasma membrane is a formidable barrier. It is a phospholipid bilayer studded with proteins, carbohydrates, and cholesterol, designed to keep extracellular material out. Nucleic acids are large, negatively charged molecules that cannot passively diffuse across this hydrophobic barrier. All transfection methods therefore rely on one of two strategies: creating transient physical disruptions in the membrane or packaging the nucleic acid into a vehicle that the cell will actively endocytose. Chemical methods—calcium phosphate, cationic lipids, and cationic polymers—operate through the endocytic pathway. The nucleic acid is complexed with a positively charged carrier, neutralizing its negative charge and condensing it into a particle of 100–500 nm in diameter. This particle binds to the negatively charged cell surface via electrostatic interactions, triggering uptake through clathrin-mediated endocytosis, caveolae-mediated endocytosis, or macropinocytosis. Once internalized, the particle resides in an endosome. Escape from the endosome is a critical and often rate-limiting step. Cationic lipids, for example, are thought to fuse with the endosomal membrane, causing destabilization and release of the nucleic acid into the cytoplasm. This "proton sponge" effect is particularly well described for polyethylenimine (PEI), a polymer that buffers the acidic endosomal environment, leading to osmotic swelling and vesicle rupture. Physical methods bypass endocytosis entirely. Electroporation applies an electric field that transiently increases the permeability of the plasma membrane, creating temporary pores through which nucleic acids diffuse directly into the cytoplasm. Microinjection physically punctures the membrane with a fine glass needle, delivering nucleic acids directly into the nucleus or cytoplasm. Biolistic delivery (gene gun) uses high-velocity microprojectiles coated with DNA to penetrate the membrane and deposit nucleic acids inside the cell. ### Intracellular Trafficking and Expression Once inside the cytoplasm, the fate of the nucleic acid depends on its type and the delivery method. Plasmid DNA must reach the nucleus to be transcribed. In non-dividing cells, this requires active transport through the nuclear pore complex, a process that is inefficient and often limits transfection success. In dividing cells, plasmid DNA gains access to the nucleus when the nuclear envelope breaks down during mitosis—one reason why transfecting cells at the appropriate confluency (typically 70–90%) improves efficiency. DNA that reaches the nucleus exists as an episome—it does not integrate into the host genome unless specifically engineered to do so. Episomal DNA is transcribed by host RNA polymerase II, producing messenger RNA (mRNA) that is exported to the cytoplasm and translated by ribosomes. Expression typically begins within 4–6 hours and peaks at 24–72 hours post-transfection, depending on the promoter strength and cell type. RNA molecules, such as siRNA or mRNA, do not need to enter the nucleus. siRNA is loaded into the RNA-induced silencing complex (RISC), where the guide strand directs the complex to complementary mRNA transcripts, leading to their cleavage and degradation. This results in gene knockdown, not knockout, and is transient. mRNA delivered by transfection is directly translated in the cytoplasm, providing a rapid but short-lived protein expression system that avoids the risks of genomic integration. ## Types of Transfection: Transient vs. Stable ### Transient Transfection Transient transfection refers to the temporary expression of a delivered gene. The nucleic acid does not integrate into the host genome, and expression is lost as the plasmid is diluted through cell division or degraded by intracellular nucleases. Expression typically lasts 2–7 days, making this approach ideal for short-term experiments: promoter analysis, protein–protein interaction studies, and rapid protein production. Transient transfection is the most common laboratory method because it is fast, relatively simple, and does not require drug selection. The percentage of cells expressing the transgene—the transfection efficiency—varies widely by cell type and method. HEK293 cells can achieve efficiencies above 90% with lipid-based reagents, while primary cells may struggle to reach 20%. A key advantage of transient transfection is that it can be used to deliver multiple plasmids simultaneously, enabling co-expression of a gene of interest with a reporter such as green fluorescent protein (GFP) or luciferase. This allows researchers to identify successfully transfected cells and normalize for transfection efficiency. ### Stable Transfection and Selection Stable transfection occurs when the delivered DNA integrates into the host genome, either randomly through non-homologous end joining or at a specific locus through [homologous recombination](/knowledge/molecular-biology/homologous-recombination). The transgene is then replicated along with the host genome and passed to daughter cells, resulting in permanent expression. To generate a stable cell line, the plasmid must include a selectable marker—a gene conferring resistance to an antibiotic such as Geneticin (G418), hygromycin B, or puromycin. After transfection, cells are cultured in medium containing the antibiotic. Only cells that have integrated the plasmid and express the resistance gene survive. This selection process takes 2–4 weeks, after which surviving colonies can be isolated, expanded, and characterized. Stable cell lines are essential for long-term experiments, consistent protein production, and applications such as inducible gene expression systems. The process is more labor-intensive than transient transfection and requires careful clonal selection to ensure uniform expression levels. For industrial applications, stable pools are often generated first, followed by single-cell cloning to identify high-producing clones. This workflow is central to [Cell Line Development](/knowledge/molecular-biology/cell-line-development), particularly for therapeutic protein production in [CHO Cell](/knowledge/molecular-biology/cho-cell) systems. ## Chemical Transfection Methods ### Calcium Phosphate Precipitation Calcium phosphate transfection is one of the oldest chemical methods, first described in the 1970s. It is based on the formation of a calcium phosphate–DNA co-precipitate that is taken up by cells through endocytosis. The protocol involves mixing DNA with a calcium chloride solution (typically 2 M CaCl₂) and then adding this dropwise to a phosphate-buffered saline solution (2× HEPES-buffered saline, pH 7.05) while bubbling air through the mixture. The resulting precipitate contains DNA embedded in a calcium phosphate lattice. This suspension is added directly to cultured cells. The critical parameter is the pH of the HEPES-buffered saline. A pH that is too high or too low produces a precipitate that is either too fine (poor uptake) or too coarse (cytotoxic). The precipitate must be allowed to form for 20–30 minutes at room temperature before addition to cells. After 4–16 hours of incubation, the medium is replaced to remove the precipitate, which can be toxic to cells over extended periods. Calcium phosphate transfection is inexpensive and works well for adherent cell lines such as HEK293, but it is less efficient for suspension cells and primary cultures. It is also sensitive to small variations in protocol, making it less reproducible than newer reagents. ### Lipofection Lipofection, also known as lipid-mediated transfection, uses cationic lipids to deliver nucleic acids. These lipids consist of a positively charged head group and one or two hydrophobic tails. When mixed with nucleic acids in an aqueous solution, they self-assemble into liposomes or lipoplexes, with the nucleic acid condensed in the interior and the cationic head groups facing outward. The positively charged lipoplex binds to the negatively charged cell membrane, facilitating uptake through endocytosis. Once inside the endosome, the lipid components are thought to fuse with the endosomal membrane, releasing the nucleic acid into the cytoplasm. This "flip-flop" mechanism is promoted by the ionizable nature of many cationic lipids, which become protonated at the acidic endosomal pH. Lipofection reagents are commercially available from multiple suppliers (Lipofectamine, FuGENE, TransIT) and are formulated for different cell types. The standard protocol involves diluting the DNA in serum-free medium, adding the lipid reagent, incubating for 15–30 minutes to allow complex formation, and then adding the mixture to cells. The optimal DNA-to-lipid ratio must be determined empirically for each cell line, typically ranging from 1:1 to 1:3 (w/w). Lipofection is versatile, efficient, and works with DNA, siRNA, and mRNA. It is the method of choice for most routine laboratory applications. However, cationic lipids can be cytotoxic at high concentrations, and some cell types—particularly primary cells and suspension cultures—are resistant to lipid-mediated delivery. ### Polymer-Based Reagents Cationic polymers, most notably polyethylenimine (PEI), offer an alternative chemical approach. PEI is a highly branched polymer with a high density of amine groups that are protonated at physiological pH. It condenses DNA into positively charged nanoparticles and facilitates endosomal escape through the proton sponge effect: the buffering capacity of the amines causes an influx of chloride ions and water into the endosome, leading to osmotic swelling and rupture. [PEI transfection](/knowledge/molecular-biology/pei-transfection) is performed by mixing DNA with PEI at a nitrogen-to-phosphate (N/P) ratio of 5–10, incubating for 15–30 minutes, and adding the complex to cells. It is particularly popular for large-scale transient transfection of suspension cells in bioreactors, as it is inexpensive and scalable. The detailed protocol for [Pei Transfection](/knowledge/molecular-biology/pei-transfection) is a core technique in industrial protein production. Other polymers used for transfection include poly-L-lysine, chitosan, and dendrimers. Each has distinct characteristics in terms of transfection efficiency, cytotoxicity, and compatibility with serum. Polymer-based methods are generally less efficient than lipofection for many cell lines but offer advantages in cost and scalability. ## Physical Transfection Methods ### Electroporation Electroporation uses a brief, high-voltage electric pulse to create transient pores in the plasma membrane. The cell membrane acts as a capacitor, and when an external electric field is applied, the transmembrane potential increases. When this potential exceeds a threshold (approximately 0.5–1 V), the membrane breaks down locally, forming hydrophilic pores of 10–20 nm in diameter. These pores allow nucleic acids to enter the cell by diffusion or electrophoresis. The procedure involves suspending cells in a conductive buffer containing the nucleic acid, placing the suspension in a cuvette with two electrodes, and applying one or more square-wave or exponential-decay pulses. Typical parameters are 100–300 V and 25–500 µF for exponential decay, or 1–3 kV/cm for square-wave pulses. Optimal parameters must be determined for each cell type; excessive voltage causes irreversible membrane damage and cell death, while insufficient voltage fails to create pores. Electroporation is highly efficient—often exceeding 90% for many cell types—and works for both adherent and suspension cells, including primary cells and difficult-to-transfect lines. It is also the method of choice for delivering large constructs, such as bacterial artificial chromosomes (BACs), that are too large for chemical methods. The main drawbacks are the requirement for specialized equipment, the need to optimize pulse parameters, and significant cell mortality (typically 20–50%). ### Microinjection Microinjection is the direct physical delivery of nucleic acids into the nucleus or cytoplasm using a fine glass micropipette. The pipette tip has a diameter of 0.5–1 µm and is controlled by a micromanipulator. The cell is held in place by a second pipette, and the injection pipette penetrates the membrane to deliver a defined volume (typically 10–100 fL) of solution. This method is technically demanding and low-throughput—a skilled operator can inject 100–200 cells per hour—but it offers several unique advantages. Microinjection allows precise control over the amount of nucleic acid delivered, can be used on individual cells within a heterogeneous population, and is effective for cells that are resistant to other methods. It is commonly used to create [transgenic animals](/knowledge/molecular-biology/transgenic-animal) by injecting DNA into the pronucleus of fertilized oocytes, and for studying single-cell responses. ### Biolistic Particle Delivery Biolistic particle delivery, commonly called the gene gun, uses high-velocity microprojectiles to penetrate cells. Gold or tungsten particles (0.5–2 µm in diameter) are coated with nucleic acid and accelerated toward the target cells using a helium gas pulse or electric discharge. The particles physically penetrate the cell membrane and deposit the nucleic acid inside. This method was originally developed for plant cells, which have rigid cell walls that resist other transfection methods, but it is also used for animal tissues, particularly in gene therapy and vaccine development. Biolistic delivery is effective for tissues in situ, such as skin or muscle, and for cells in culture. The main limitations are the requirement for specialized equipment, the potential for tissue damage, and the relatively low efficiency compared to other methods. ## Biological Transfection: Viral Vectors ### Retrovirus and Lentivirus Vectors Viral vectors exploit the natural ability of viruses to deliver genetic material into cells. Retroviruses and lentiviruses are RNA viruses that reverse-transcribe their genome into DNA and integrate it into the host genome. This integration makes them ideal for stable transfection (transduction) and long-term gene expression. Retroviral vectors are derived from murine leukemia virus (MLV) and can transduce dividing cells only. They are produced by co-transfecting a packaging cell line (such as HEK293T) with three plasmids: a transfer vector containing the gene of interest flanked by long terminal repeats (LTRs), a packaging plasmid encoding Gag, Pol, and Env proteins, and an envelope plasmid encoding a viral envelope glycoprotein. The resulting viral particles bud from the packaging cells and are harvested from the culture medium. [Lentiviral vectors](/knowledge/molecular-biology/lentiviral-vector), derived from human immunodeficiency virus (HIV-1), can transduce both dividing and non-dividing cells because they encode proteins that facilitate nuclear import. This makes them the vector of choice for transducing primary cells, neurons, and hematopoietic stem cells. Lentiviral vectors also have a larger cargo capacity (up to 8–10 kb) than retroviral vectors. A critical safety feature of modern viral vectors is their replication-incompetence: the viral genome is split across multiple plasmids, and the packaging and envelope sequences are deleted from the transfer vector. This ensures that the produced viral particles can infect target cells but cannot replicate to produce new virus. ### Adenoviral and AAV Vectors Adenoviral vectors are derived from human adenoviruses, which cause mild respiratory infections. They have a double-stranded DNA genome of approximately 36 kb, of which up to 8 kb can be replaced with a transgene in first-generation vectors. Adenoviruses transduce both dividing and non-dividing cells and do not integrate into the host genome—they remain episomal. This results in high-level but transient expression, making adenoviral vectors suitable for vaccine development and gene therapy applications where short-term expression is desired. Adeno-associated viruses (AAVs) are small, non-pathogenic parvoviruses that require a helper virus (adenovirus or herpesvirus) for replication. Recombinant AAV vectors have a cargo capacity of approximately 4.7 kb and can transduce both dividing and non-dividing cells. In the absence of the viral Rep protein, the recombinant genome remains predominantly episomal, with a small fraction integrating at a specific site on chromosome 19. AAV vectors are notable for their low immunogenicity and long-term expression in non-dividing tissues, making them the leading platform for in vivo gene therapy. The choice of viral vector depends on the experimental requirements: transient or stable expression, dividing or non-dividing cells, cargo size, and immunogenicity. Viral transduction is generally more efficient than chemical or physical transfection, but it requires additional biosafety precautions and is more labor-intensive to produce. ## Factors Affecting Transfection Efficiency ### Cell Health and Confluency The physiological state of the cells is the single most important determinant of transfection success. Cells must be healthy, actively dividing, and free from contamination. Mycoplasma infection is a particular concern, as it can reduce transfection efficiency by up to 90% without causing obvious cytopathic effects. Routine testing for mycoplasma is essential. Confluency at the time of transfection is critical. For most adherent cell lines, 70–90% confluency is optimal. At lower densities, cells may not be actively dividing, and the reduced cell–cell contact can affect uptake. At higher densities, contact inhibition slows division and reduces the accessibility of the cell surface to transfection complexes. For lipid-based methods, the recommended confluency is typically 70–80%; for electroporation, cells are usually harvested at 80–90% confluency and resuspended at a defined density. Cells should be passaged regularly and used at low passage numbers. High-passage cells often exhibit altered membrane properties and reduced transfection efficiency. Proper [Cell Passaging](/knowledge/molecular-biology/cell-passaging) and maintenance in [Animal Cell Culture](/knowledge/molecular-biology/animal-cell-culture) are prerequisites for reproducible transfection. ### DNA Quantity and Purity The quality of the nucleic acid preparation directly impacts transfection efficiency. Plasmid DNA should be purified using endotoxin-free kits, as endotoxins (lipopolysaccharides from bacterial cell walls) are toxic to many cell types and can reduce transfection efficiency. The DNA should be free of protein, RNA, and genomic DNA contamination, as these impurities can interfere with complex formation. The A260/A280 ratio should be between 1.8 and 2.0, indicating pure DNA. The DNA should be in a buffer that is compatible with the transfection reagent—typically Tris-EDTA (TE) buffer or nuclease-free water. The amount of DNA used per well depends on the plate format and the method. For a 6-well plate, 1–2.5 µg of DNA is typical for lipofection; for electroporation, 5–10 µg per reaction is common. The ratio of DNA to transfection reagent is another critical variable. Too little reagent fails to condense the DNA effectively; too much reagent causes cytotoxicity. This ratio must be optimized for each cell line and reagent combination. ### Serum and Antibiotics Serum in the culture medium can interfere with chemical transfection. Cationic lipids and polymers can bind to serum proteins, reducing the effective concentration of the transfection complex. For this reason, many protocols recommend performing transfection in serum-free medium or in medium with reduced serum (2–5%). However, some reagents are formulated to work in the presence of serum, and the manufacturer's instructions should be followed. Antibiotics, particularly penicillin and streptomycin, can also interfere with transfection. These antibiotics are toxic to cells at the concentrations used during transfection, and they can affect the endocytic pathway. It is standard practice to perform transfection in antibiotic-free medium and to add antibiotics only after the transfection complexes have been removed. ## Applications of Cell Transfection ### Gene Expression and Functional Studies The most fundamental application of transfection is to express a gene of interest and study its function. This includes overexpression studies to examine the effect of a protein on cellular processes, complementation assays to rescue a mutant phenotype, and reporter gene assays to measure promoter activity. A typical overexpression experiment involves cloning the gene of interest into an expression plasmid under the control of a strong promoter, such as the cytomegalovirus (CMV) immediate-early promoter. The plasmid is transfected into cells, and protein expression is confirmed by western blotting, immunofluorescence, or enzymatic activity assays. Co-transfection with a reporter plasmid, such as one encoding GFP or firefly luciferase, allows normalization for transfection efficiency. Transfection is also used to produce recombinant proteins for biochemical and structural studies. Large-scale transient transfection of suspension HEK293 or CHO cells in bioreactors can produce milligram quantities of protein within days. This approach is faster than generating stable cell lines and is widely used in drug discovery and structural biology. For industrial-scale production, [Cell-free Protein Synthesis System](/knowledge/molecular-biology/cell-free-protein-synthesis-system) offers an alternative that avoids the complexities of cell culture. ### [RNA Interference](/blog/guides/rna-interference-a-practical-guide-to-gene-silencing-mechanisms) RNA interference (RNAi) is a powerful tool for gene silencing. Small interfering RNAs (siRNAs) are 21–23 nucleotide double-stranded RNA molecules that are processed by the RISC to guide the cleavage of complementary mRNA transcripts. Transfection of siRNA into cells results in sequence-specific gene knockdown, allowing researchers to study the loss-of-function phenotype. The protocol for [siRNA Transfection](/knowledge/molecular-biology/sirna-transfection) differs from DNA transfection in several respects. siRNA is much smaller than plasmid DNA and requires lower reagent concentrations. The efficiency of knockdown is typically assessed by quantitative PCR (qPCR) or western blotting 24–72 hours post-transfection. Off-target effects are a concern, and appropriate controls—including a non-targeting siRNA and a rescue experiment—are essential. Short hairpin RNAs (shRNAs) expressed from plasmid or viral vectors provide a more stable form of RNAi. The shRNA is transcribed in the nucleus, processed by the enzyme Drosha, and exported to the cytoplasm, where it is further processed by Dicer to generate functional siRNA. shRNA can be stably integrated into the genome, providing long-term knockdown. ### CRISPR Gene Editing CRISPR-Cas9 has revolutionized gene editing, and transfection is the primary method for delivering the editing components. The standard approach involves transfecting a plasmid encoding the Cas9 nuclease and a guide RNA (gRNA) that directs Cas9 to a specific genomic locus. Alternatively, Cas9 can be delivered as mRNA or as a purified protein complexed with the gRNA (ribonucleoprotein, RNP). The choice of delivery method affects editing efficiency and off-target effects. Plasmid-based delivery is simple but results in prolonged Cas9 expression, which can increase off-target editing. RNP delivery is more precise but requires electroporation or specialized transfection reagents. After editing, cells are typically single-cell cloned and screened for the desired modification. Transfection is also used to deliver donor templates for homology-directed repair (HDR), enabling the introduction of specific mutations or reporter genes. The efficiency of HDR is often low (1–10%), and various strategies—such as inhibiting non-homologous end joining or synchronizing cells in S phase—are used to improve it. ## Common Pitfalls and Troubleshooting ### Low Efficiency Causes Low transfection efficiency is the most common problem encountered in the laboratory. The causes are numerous, but the most frequent include: - **Poor cell health**: Cells that are overgrown, underfed, or contaminated with mycoplasma will transfect poorly. Start with a fresh vial of cells at low passage number. - **Incorrect confluency**: Transfecting at too high or too low density reduces efficiency. Optimize the seeding density for each cell line. - **DNA quality**: Impure DNA, degraded DNA, or DNA contaminated with endotoxins will reduce efficiency. Use high-quality, endotoxin-free plasmid preparations. - **Wrong DNA-to-reagent ratio**: The optimal ratio varies by cell line and reagent. Perform a titration experiment to determine the optimal conditions. - **Serum interference**: Serum can inhibit complex formation. Follow the manufacturer's instructions regarding serum-free conditions. ### Cytotoxicity Issues Cytotoxicity is the second most common problem. Transfection reagents are inherently toxic, and the balance between efficiency and viability is delicate. Signs of cytotoxicity include cell rounding, detachment, and reduced viability as measured by trypan blue exclusion or metabolic assays such as MTT. The [Calculate Cell Viability](/knowledge/molecular-biology/calculate-cell-viability) protocol is essential for monitoring this. To reduce cytotoxicity, consider the following: - **Reduce the amount of transfection reagent**: Use the minimum amount that achieves acceptable efficiency. - **Shorten the exposure time**: Remove the transfection complexes after 4–6 hours instead of leaving them overnight. - **Use a gentler reagent**: Some reagents are formulated to be less toxic, particularly for sensitive cell types. - **Optimize cell density**: Higher cell densities can tolerate higher reagent concentrations. ### Optimization Strategies Optimization is an empirical process that should be performed systematically. The key variables are cell density, DNA amount, reagent amount, and incubation time. A typical optimization experiment involves a matrix of conditions: 3 cell densities × 3 DNA amounts × 3 reagent amounts. Transfection efficiency is assessed using a reporter gene such as GFP, and cell viability is measured in parallel. Other variables to consider include the choice of transfection reagent, the buffer used to dilute the DNA, and the presence of enhancers. Some reagents are specifically formulated for difficult-to-transfect cells, such as primary neurons or suspension cells. For these cells, electroporation or viral transduction may be more reliable. ## Frequently Asked Questions ### What is cell transfection? Cell transfection is the process of introducing exogenous nucleic acids—DNA, RNA, or oligonucleotides—into eukaryotic cells. The goal is to achieve a biological effect, such as protein expression, gene silencing, or genome editing. Transfection can be transient, where expression lasts for a few days, or stable, where the nucleic acid integrates into the host genome and is passed to daughter cells. ### What is the difference between transfection and transduction? Transfection refers to the introduction of nucleic acids into cells using chemical or physical methods, such as lipofection or electroporation. Transduction refers specifically to the delivery of nucleic acids using viral vectors. Transduction is generally more efficient and can be used for both dividing and non-dividing cells, but it requires additional biosafety precautions and is more labor-intensive. ### What are the main types of transfection? The main types are transient and stable transfection. Transient transfection results in temporary expression that is lost within days, while stable transfection results in permanent expression through genomic integration. Stable transfection requires the use of a selectable marker and takes 2–4 weeks to establish. ### How does lipofection work? Lipofection uses cationic lipids that self-assemble with nucleic acids into lipoplexes. The positively charged lipoplex binds to the negatively charged cell membrane and is taken up by endocytosis. The lipid components then destabilize the endosomal membrane, releasing the nucleic acid into the cytoplasm. Lipofection is efficient, versatile, and works with DNA, siRNA, and mRNA. ### What is electroporation? Electroporation is a physical transfection method that uses a brief electric pulse to create transient pores in the plasma membrane. Nucleic acids diffuse through these pores into the cytoplasm. Electroporation is highly efficient and works for many cell types, including primary cells, but it requires specialized equipment and causes significant cell mortality. ### Why is my transfection efficiency low? Low efficiency is usually caused by poor cell health, incorrect confluency, impure DNA, or suboptimal DNA-to-reagent ratios. Mycoplasma contamination is a common hidden cause. Systematic optimization of cell density, DNA amount, and reagent amount is the most reliable way to improve efficiency. ### What are the applications of transfection? Transfection is used for gene expression studies, recombinant protein production, RNA interference, CRISPR gene editing, and the generation of stable cell lines. It is also used in gene therapy and vaccine development, where nucleic acids are delivered to cells to correct genetic defects or elicit immune responses. ## Key Takeaways - Transfection is the introduction of exogenous nucleic acids into eukaryotic cells; transduction uses viral vectors, and transformation refers to bacterial DNA uptake or oncogenic conversion. - Transient transfection provides short-term expression without genomic integration; stable transfection requires drug selection and results in permanent expression. - Chemical methods (calcium phosphate, lipofection, polymers) rely on endocytosis; physical methods (electroporation, microinjection, biolistics) bypass endocytosis by creating membrane disruptions. - Viral vectors, particularly lentivirus and AAV, offer the highest efficiency and can transduce non-dividing cells, but require biosafety precautions. - Transfection efficiency depends on cell health, confluency, DNA quality, reagent-to-DNA ratio, and the presence of serum and antibiotics. - Applications include gene overexpression, RNAi-mediated knockdown, CRISPR genome editing, and recombinant protein production. - Troubleshooting low efficiency requires systematic optimization of cell density, DNA amount, and reagent concentration, along with routine [mycoplasma testing](/knowledge/molecular-biology/mycoplasma-testing). ## Further Reading - Kim TK, Eberwine JH. *Mammalian cell transfection: the present and the future*. Analytical and bioanalytical chemistry. 2010. [PubMed 20549496](https://doi.org/10.1007/s00216-010-3821-6) - Duckert B et al. *Single-cell transfection technologies for cell therapies and gene editing*. Journal of controlled release : official journal of the Controlled Release Society. 2021. [PubMed 33160005](https://doi.org/10.1016/j.jconrel.2020.10.068) - Kumar ARK et al. *Materials for Improving Immune Cell Transfection*. Advanced materials (Deerfield Beach, Fla.). 2021. [PubMed 33860598](https://doi.org/10.1002/adma.202007421) - Longo PA et al. *Transient mammalian cell transfection with polyethylenimine (PEI)*. Methods in enzymology. 2013. [PubMed 24011049](https://doi.org/10.1016/B978-0-12-418687-3.00018-5) - Kheirolomoom A et al. *In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift*. Biomaterials. 2022. [PubMed 35078042](https://doi.org/10.1016/j.biomaterials.2021.121339) - Wauford N et al. *Rapid Development of Cell State Identification Circuits with Poly-Transfection*. Journal of visualized experiments : JoVE. 2023. [PubMed 36912522](https://doi.org/10.3791/64793)
## Related Clinical & Scientific Guides * [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway) * [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor) * [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)